Stockreport

Lexaria Awards CRO Contract for 12-Week DehydraTECH GLP-1 Chronic Human Study [Yahoo! Finance]

Lexaria Bioscience Corp.  (LEXX) 
PDF KELOWNA, BC / ACCESSWIRE / June 18, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX,)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platf [Read more]